Product
WJ-MSC infusion
1 clinical trial
3 indications
Indication
Allogeneic DiseaseIndication
Acute GVHDIndication
Graft FailureClinical trial
Wharton's Jelly Mesenchymal Stromal Cell (WG-MSC) Injections as GVHD Prophylaxis in Hematopoietic Allogeneic Stem Cell Transplantation With an Haplo-identical Donor : a Dose Escalation StudyStatus: Not yet recruiting, Estimated PCD: 2025-09-01